Table 1 Hematologic and clinical... | American Society of Hematology

Table 1

Hematologic and clinical characteristics for each of the patient groups

	AL (n = 220)	AL + MM I (n = 26)	MGUS (n = 151)	MM I (n = 29)	AL ± MM I vs MGUS/MM I, P
Median age, y (range)	63 (36-82)	57 (41-80)	59 (29-87)	64 (40-82)	.38†
Sex, no. male/female	127/93	12/14	74/77	17/12	.24‡
Light chain, no. κ/λ	49/170*	8/18	99/51*	16/13	< .001‡
Intact immunoglobulin, no. yes/no	90/129	14/12	144/7	29/0	< .001‡
Median plasmacytosis, % (range)	9 (1-29)	23 (4-44)	9 (1-28)	30 (3-50)	.50†

	AL (n = 220)	AL + MM I (n = 26)	MGUS (n = 151)	MM I (n = 29)	AL ± MM I vs MGUS/MM I, P
Median age, y (range)	63 (36-82)	57 (41-80)	59 (29-87)	64 (40-82)	.38†
Sex, no. male/female	127/93	12/14	74/77	17/12	.24‡
Light chain, no. κ/λ	49/170*	8/18	99/51*	16/13	< .001‡
Intact immunoglobulin, no. yes/no	90/129	14/12	144/7	29/0	< .001‡
Median plasmacytosis, % (range)	9 (1-29)	23 (4-44)	9 (1-28)	30 (3-50)	.50†

These patient groups include one patient with a gammopathy biclonal for κ and λ each.

Exact Wilcoxon rank-sum test.

Fisher exact test.